Partnerships
17 May 2023
SpeeDx adds Biosapientia to Distribution Network
Partnership with Biosapientia expands SpeeDx product availability in France SYDNEY, AUSTRALIA – (May 17, 2023). SpeeDx have announced signing a new distribution partner, further extending access for customers to market leading...
18 October 2022
SpeeDx Supports Papua New Guinea with COVID-19 Tests
Provision of SARS-CoV-2 tests reinforces PNG sovereign capacity to respond to ongoing pandemic. SpeeDx announce they have donated PlexPCR® SARS-CoV-2 tests and PlexPrime® SARS-CoV-2 Genotyping reagents to support Papua New Guinea...
16 September 2022
The Australian Academy of Technological Sciences and Engineering (ATSE) has today launched a new industry internship program for STEM graduates
The Australian Academy of Technological Sciences and Engineering (ATSE) has today launched a new industry internship program for STEM graduates, in partnership with leading Australian medical-tech, energy, intellectual property and...
24 August 2022
AMR Hub | A world-first partnership between industry, researchers and end users to transform antimicrobial resistance (AMR) and stewardship
Congratulations to the team at AMR Hub on your official launch. SpeeDx is thrilled to work alongside you in the fight against antimicrobial resistance. On 3 August 2022, the AMR Hub...
13 May 2022
SpeeDx Awarded REDI Fellowship To Support Next Generation Resistance Guided Therapy For Mycoplasma genitalium
Collaboration with researchers at The University of Queensland aims to improve detection of antimicrobial resistant STI superbug The REDI Fellowship Program is part of MTPConnect’s $32 million Researcher Exchange and Development within Industry...
28 September 2021
SpeeDx announces investment in SynGenis
SpeeDx announced investment in SynGenis Pty Ltd., an experienced oligonucleotide manufacturer based in Western Australia. The partnership will bolster internal capacity of SpeeDx to support large-scale increases in manufacturing while developing...
30 June 2021
SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution
SpeeDx Pty, Ltd. and MolGen announced the signing of an agreement to collaborate on supply and distribution of clinical diagnostics products and instrumentation across Europe and Asia Pacific. The partnership...
11 May 2021
SpeeDx Receives CARB-X Funding to Develop Rapid Point-of-Care Diagnostic
SpeeDx announced it has been awarded up to US $1.8 million from CARB-X to address the rising threat of drug-resistant bacteria. Funds will be used to develop a rapid test for the combined...
27 April 2021
Microbix & SpeeDx Form Exclusive Collaboration
Microbix Biosystems Inc. (TSX: MBX. OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and SpeeDx Pty. Ltd. announced a collaboration where Microbix will exclusively develop Quality Assessment Products to...